CXL controversy 2018: Hype or reality?
Prof. Hafezi in a controversy about Cross-Linking with Prof. Damien Gatinel at the Science2Clinix-Kongress in Bangalore.
Prof. Farhad Hafezi
June 15, 2018
Prof. Hafezi in a controversy about Cross-Linking with Prof. Damien Gatinel at the Science2Clinix-Kongress in Bangalore.
The ELZA Institute was part of the main lecture program of the 2018 congress of the German ophthalmic surgeons, DOC in Nuremberg.
Prof. Hafezi gives an overview at Science2Clinix 2018 in Bangalore about ELZA’s latest research results on corneal cross-linking research.
The Narayana Nethralaya Hospital in Bangalore, India has become a leader in the field of corneal cell biology in the past 5 years
The ELZA founder Farhad Hafezi has been voted by his peers onto the Powerlist 2018, a list of the 100 top most influential people in ophthalmology.
The ELZA Institute was represented at the 2018 Meeting of the Moroccon Cataract and Refractive Surgeons in Tanger
Fifteen years into the clinical application of corneal cross-linking, we are collecting a growing number of long-term results from patients
The ELZA Institute looks back at a successful 2017 in clinics, research and education
ELZA participates at the 2017 meeting of the Cornea Society of India.
Keratoconus affects about 1 in 2,000 people in the general population, but 1 in 7 Down syndrome individuals are affected
